Elanco Animal Health Research and Development Expenses 2016-2024 | ELAN

Elanco Animal Health annual/quarterly research and development expenses history and growth rate from 2016 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Elanco Animal Health research and development expenses for the quarter ending September 30, 2024 were $0.087B, a 1.16% increase year-over-year.
  • Elanco Animal Health research and development expenses for the twelve months ending September 30, 2024 were $342M, a 4.27% increase year-over-year.
  • Elanco Animal Health annual research and development expenses for 2023 were $0.327B, a 1.87% increase from 2022.
  • Elanco Animal Health annual research and development expenses for 2022 were $0.321B, a 13.01% decline from 2021.
  • Elanco Animal Health annual research and development expenses for 2021 were $0.369B, a 12.16% increase from 2020.
Elanco Animal Health Annual Research and Development Expenses
(Millions of US $)
2023 $327
2022 $321
2021 $369
2020 $329
2019 $270
2018 $247
2017 $252
2016 $266
2015 $291
Elanco Animal Health Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $87
2024-06-30 $89
2024-03-31 $87
2023-12-31 $79
2023-09-30 $86
2023-06-30 $81
2023-03-31 $81
2022-12-31 $80
2022-09-30 $78
2022-06-30 $82
2022-03-31 $81
2021-12-31 $92
2021-09-30 $94
2021-06-30 $94
2021-03-31 $89
2020-12-31 $115
2020-09-30 $88
2020-06-30 $59
2020-03-31 $67
2019-12-31 $67
2019-09-30 $70
2019-06-30 $69
2019-03-31 $64
2018-12-31 $61
2018-09-30 $59
2018-06-30 $61
2018-03-31 $65
2017-12-31
2017-09-30 $62
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.580B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00